Dissemination of thrombolysis for acute ischemic stroke across a nation: Experiences from the swedish stroke register, 2003 to 2008

Stroke

Volumn 41, Issue 6, 2010, Pages 1115-1122

  Eriksson, Marie ^a   Jonsson, Fredrik ^a   Appelros, Peter ^b   Åsberg, Kerstin Hulter ^c   Norrving, Bo ^d   Stegmayr, Birgitta ^e   Terént, Andreas ^f   Asplund, Kjell ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Enkoping Hospital   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute ischemic stroke; Implementation; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG USE; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REGISTER; SEX; STROKE UNIT; SWEDEN; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; GUIDELINE ADHERENCE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; SWEDEN; THROMBOLYTIC THERAPY;

EID: 77953157932     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.577106     Document Type: Article

References (19)

1. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009;4:CD000213.
2. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64:654-659.
3. Dirks M, Niessen LW, Huijsman R, van Wijngaarden J, Minkman MM, Franke CL, van Oostenbrugge RJ, Koudstaal PJ, Dippel DW. Promoting acute thrombolysis for ischaemic stroke (PRACTISE). Int J Stroke. 2007; 2:151-159.
4. Perez de la Ossa N, Millan M, Arenillas JF, Sanchez-Ojanguren J, Palomeras E, Dorado L, Guerrero C, Davalos A. Influence of direct admission to comprehensive stroke centers on the outcome of acute stroke patients treated with intravenous thrombolysis. J Neurol. 2009;256:1270-1276.
5. Albers GW, Olivot JM. Intravenous alteplase for ischaemic stroke. Lancet. 2007;369:249-250.
6. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use. Stroke. 2008;39:924-928.
7. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study group. Stroke. 2003;34:1106-1113.
8. Starmark JE, Stålhammar D, Holmgren E. The Reaction Level Scale (RLS85). Manual and guidelines. Acta Neurochir (Wien). 1988;91:12-20.
9. Eriksson M, Appelros P, Norrving B, Terént A, Stegmayr B. Assessment of functional outcome in a national quality register for acute stroke: can simple self-reported items be transformed into the modified Rankin Scale? Stroke. 2007;38:1384-1386.
10. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kohrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Stroke. 2008;39:3316-3322.
11. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2002;1:CD000197.
12. Appelros P, Hogeras N, Terént A. Case ascertainment in stroke studies: the risk of selection bias. Acta Neurol Scand. 2003;107:145-149.
13. Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J. Use of thrombolysis in acute ischemic stroke: analysis of the nationwide inpatient sample 1999 to 2004. Ann Emerg Med. 2007;50:99-107.
14. Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth L. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke. 2009;40:1743-1749.
15. Kleindorfer DO, Lindsell CJ, Broderick JP, Flaherty ML, Woo D, Ewing I, Schmit P, Moomaw C, Alwell K, Pancioli A, Jauch E, Khoury J, Miller R, Schneider A, Kissela BM. Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack. Stroke. 2006;37:1508-1513.
16. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis. 2007;24:1-10.
17. Bravo Y, Marti-Fabregas J, Cocho D, Rodriguez-Yanez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Marti-Vilalta JL. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis. Cerebrovasc Dis. 2008;26:126-133.
18. Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WAT, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR. A review of the evidence for the use of telemedicine within stroke systems of care. Stroke. 2009;40:2616-2634.
19. van Wijngaarden JD, Dirks M, Huijsman R, Niessen LW, Fabbricotti IN, Dippel DW. Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture. Stroke. 2009;40:3390-3392.